TELL ME MORE

ABOUT THIS CLINICAL TRIAL for MIGRAINES in CHILDREN

This is an Double Blind, Placebo Controlled Phase 3 Study of an Investigational Medicine for Migraine Patients Ages 6 – 17 Years.

Clinical Trial for Migraine in Children

Clinical Trial for Migraines in Children

Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana

Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age.  Migraine occurs more frequently in adolescents compared with the younger pediatric age groups.  There is a significant increase in migraine incidence in females after puberty. In children and adolescents, headache and migraine can result in missed school days, poorer academic performance and a negative impact on quality of life.  There are few treatments approved for the acute treatment of migraine in adolescents, and only 1 treatment approved for children aged 6 to 11 years. Thus, there remains a significant unmet need for the acute treatment of migraine in children and adolescents.  This is a double-blind, placebo-controlled, phase 3 study of an investigational medicine for acute migraine in children ages 6 – 17.  Patient volunteers will have an option to enter a 52 week long-term open-label extension study.  Click here for more information on living with pediatric migraine.

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimbursement up to $550 may be available.

Watch a short presentation on Migraines

View More Studies

[table id=1 /]

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest